TrialEuropean journal of clinical pharmacology2003

A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.

Roger Messin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.